Results 81 to 90 of about 25,693 (232)

Features of exotoxin production of vaccine strains of anthrax pathogen for use in the veterinary industry

open access: yesUkrainian Journal of Veterinary Sciences
Exotoxins that produce vaccine strains of the anthrax pathogen are the main source of immunogenicity of anti-selective vaccines used in veterinary medicine.
H. Zaviriukha   +4 more
doaj   +1 more source

Calmodulin in Complex with Proteins and Small Molecule Ligands: Operating with the Element of Surprise. Implications for Structure-Based Drug Design [PDF]

open access: yes, 2009
Calmodulin plays a role in several life processes, its flexibility allows binding of a number of different ligands from small molecules to amphiphilic peptide helices and proteins. Through the diversity of its functions, it is quite difficult to find new
Keserű, György Miklós   +2 more
core  

Use of single-chain antibody derivatives for targeted drug delivery [PDF]

open access: yes, 2016
Single-chain antibodies (scFvs), which contain only the variable domains of full-length antibodies, are relatively small molecules that can be used for selective drug delivery.
Ahmadzadeh, V.   +5 more
core   +1 more source

Biopharmaceuticals for Cancer Treatment: An Update

open access: yesCancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath   +6 more
wiley   +1 more source

Anthrax protective antigen is a calcium-dependent serine protease

open access: yesVirulence, 2018
Bacillus anthracis secretes a three component exotoxin-complex, which contributes to anthrax pathogenesis. Formation of this complex starts with the binding of protective antigen (PA) to its cellular receptor.
Lisanne Storm   +7 more
doaj   +1 more source

Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis. [PDF]

open access: yes, 2015
Bacterial-fungal interactions have important physiologic and medical ramifications, but the mechanisms of these interactions are poorly understood.
Coughlin, L.A.   +7 more
core   +3 more sources

Ultrastructural Mucosal Response to Dupilumab in Chronic Rhinosinusitis With Nasal Polyps: A Pilot Study

open access: yesClinical and Translational Allergy, Volume 16, Issue 4, April 2026.
ABSTRACT Background As monoclonal antibodies have proven effective in managing recalcitrant chronic rhinosinusitis with nasal polyps (CRSwNP), the concept of disease remission is evolving, underscoring the need for a comprehensive, multimodal evaluation of disease burden over time.
Francesco Giombi   +12 more
wiley   +1 more source

Obtaining the recombinant fusion protein OprF-aTox of Pseudomonas aeruginosa whith protective properties

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
Into the cells of Escherichia coli (strain BL21(DE3)) two forms of the fusion protein Pseudomonas aeruginosa containing the full length outer membrane protein F (OprF) and nontoxic form of Exotoxin A (without 106 C-terminal amino acid residues) have been
A. V. Soldatenkova   +4 more
doaj  

Determining Induction Conditions for Expression of Truncated Diphtheria Toxin and Pseudomonas Exotoxin A in E. coli BL21

open access: yesNovelty in Biomedicine, 2018
Background: Targeted cancer therapies have played a great role in the treatment of malignant tumors, in the recent years. Among these therapies, targeted toxin therapies such as immunotoxins, has improved the patient’s survival rate by minimizing the ...
Sahel Amoozadeh   +4 more
doaj   +1 more source

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

open access: yesPharmaceutics, 2020
The human epidermal growth factor receptor 2 (HER2) is a clinically validated target for cancer therapy, and targeted therapies are often used in regimens for patients with a high HER2 expression level.
Haozhong Ding   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy